Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

CONTEXT The adamantanes, amantadine and rimantadine, have been used as first-choice antiviral drugs against community outbreaks of influenza A viruses for many years. Rates of viruses resistant to these drugs have been increasing globally. Rapid surveillance for the emergence and spread of resistant viruses has become critical for appropriate treatment of patients. OBJECTIVE To investigate the frequency of adamantane-resistant influenza A viruses circulating in the United States during the initial months of the 2005-2006 influenza season. DESIGN AND SETTING Influenza isolates collected from 26 states from October 1 through December 31, 2005, and submitted to the US Centers for Disease Control and Prevention were tested for drug resistance as part of ongoing surveillance. Isolates were submitted from World Health Organization collaborating laboratories and National Respiratory and Enteric Virus Surveillance System laboratories. MAIN OUTCOME MEASURES Using pyrosequencing and confirmatory assays, we identified viruses containing mutations within the M2 gene that are known to confer resistance to both amantadine and rimantadine. RESULTS A total of 209 influenza A(H3N2) viruses isolated from patients in 26 states were screened, of which 193 (92.3%) contained a change at amino acid 31 (serine to asparagine [S31N]) in the M2 gene known to be correlated with adamantane resistance. Two of 8 influenza A(H1N1) viruses contained the same mutation. Drug-resistant viruses were distributed across the United States. CONCLUSIONS The high proportion of influenza A viruses currently circulating in the United States demonstrating adamantane resistance highlights the clinical importance of rapid surveillance for antiviral resistance. Our results indicate that these drugs should not be used for the treatment or prophylaxis of influenza in the United States until susceptibility to adamantanes has been reestablished among circulating influenza A isolates.

[1]  High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season. , 2006, MMWR. Morbidity and mortality weekly report.

[2]  Xiyan Xu,et al.  Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern , 2005, The Lancet.

[3]  Xiyan Xu,et al.  Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons. , 2004, Virus research.

[4]  I. Barr,et al.  Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. , 2004, Antiviral research.

[5]  H. Goto,et al.  High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. , 2003, The Journal of infectious diseases.

[6]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[7]  I. Barr,et al.  Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. , 2003, Communicable diseases intelligence quarterly report.

[8]  G. Boivin,et al.  Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  N. Cox,et al.  Low incidence of rimantadine resistance in field isolates of influenza A viruses. , 1999, The Journal of infectious diseases.

[10]  N. Cox,et al.  Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  N. Cox,et al.  Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use. , 1995, Archives of internal medicine.

[12]  R. Lamb,et al.  Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block , 1993, Journal of virology.

[13]  D. Guay,et al.  Amantadine-resistant influenza A in a nursing facility. , 1992, Archives of internal medicine.

[14]  F. Hayden,et al.  Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. , 1992, Current topics in microbiology and immunology.

[15]  F. Hayden,et al.  Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets. , 1991, The Journal of infectious diseases.

[16]  F. Hayden,et al.  Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine , 1991, Antimicrobial Agents and Chemotherapy.

[17]  F. Hayden,et al.  Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. , 1989, The New England journal of medicine.

[18]  D. Bernstein,et al.  Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. , 1989, Antiviral research.

[19]  C B Hall,et al.  Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection , 1988, Journal of virology.

[20]  F. Hayden,et al.  Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. , 1987, Infectious disease clinics of North America.

[21]  J. Skehel,et al.  Molecular basis of resistance of influenza A viruses to amantadine. , 1986, The Journal of antimicrobial chemotherapy.

[22]  R. Douglas,et al.  Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine , 1983, Antimicrobial Agents and Chemotherapy.

[23]  R. Reichman,et al.  A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. , 1982, The New England journal of medicine.

[24]  J P Fox,et al.  Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. , 1982, American journal of epidemiology.

[25]  R. Couch,et al.  Interpandemic influenza in the Houston area, 1974-76. , 1978, The New England journal of medicine.